Denali Therapeutics DNLI
NASDAQ DNLI
$19.73 -0.12 (-0.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Denali Therapeutics (DNLI) Gains (Losses) on Sale of Assets & Investments (2017 - 2026)

Updated

Analysis

Denali Therapeutics (DNLI) Gains (Losses) on Sale of Assets & Investments (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Denali Therapeutics 3.18 Bn 98.89 Mn 17.59 Mn 194.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 194.00 Mn
Jun 30, 2026 -1.29 Mn
Mar 31, 2026 -1.36 Mn
Mar 31, 2024 14.54 Mn
Dec 31, 2022 9.35 Mn
Sep 30, 2022 421,000.00
Jun 30, 2022 -3.02 Mn
Mar 31, 2022 -6.75 Mn
Dec 31, 2021 -1.98 Mn
Sep 30, 2021 -153,000.00
Jun 30, 2021 -136,000.00
Mar 31, 2021 13,000.00
Dec 31, 2020 -256,000.00
Sep 30, 2020 -540,000.00
Jun 30, 2020 -284,000.00
Mar 31, 2020 485,000.00
Dec 31, 2019 -212,000.00
Sep 30, 2019 -317,000.00
Jun 30, 2019 547,000.00
Mar 31, 2019 981,000.00
API Access

Denali Therapeutics Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=DNLI&period=max&api_key=YOUR_API_KEY